To sign up to the Graham Hancock newsletter mailing list, please click here.
David Nutt, a prominent and often controversial investigator at Imperial College London, has landed about $800,000 from the U.K.'s Medical Research Foundation to test the active ingredient in "magic mushrooms" as a possible new treatment for depression.
Working with the knowledge that psilocybin has been linked to long-term relief for cases of serious depression, Nutt has lined up a manufacturer able to produce a dose that can be injected in about 30 patients. Investigators will take brain scans of the volunteers to help determine how the therapy works.
Back to Previous...
Go to News Desk...
Enjoy the newsdesk? Please tell others about it:Tweet
Dedicated Servers and Cloud Servers by Gigenet. Invert Colour Scheme / Default